% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mtdsus mtdsus Oct 19, 2012 1:31 PM Flag

    NASH-Liver disease affects 2-5% of Americans -Reason for Epadel phase 2 trials.

    Mochida which sold Epadel(90% pure EPA) in Japan is trying to extend Epadel use in other big area.There are 7-20 million who suffer from this Liver disease-silently.
    It will be interesting to watch phase 2 trials for Epadel in Japan.

2.12-0.09(-4.07%)Sep 1 3:59 PMEDT